| ANGES, INC. |
| Japan |
| Gesundheit |
| JP3127700007 / 779518 |
| AJW (Frankfurt) |
| FRA:AJW, ETR:AJW, AJW:GR |
| - |
| https://www.anges.co.jp/ |
|
Anges Inc. is a biotechnology company distinguished for its contributions to advanced genetic medicine research. The company's primary focus lies in the development of DNA-based therapies, which aim to address critical needs in various medical fields..
>Volltext.. |
| 126.93 Mio. EUR |
| 117.01 Mio. EUR |
| 4.83 Mio. EUR |
| -28.15 Mio. EUR |
| -28.32 Mio. EUR |
| -0.08 EUR |
| 0.3 Mio. EUR |
| 10.4 Mio. EUR |
| - |
| 0.84 |
| 35.81% |
| 81.79% |
| - |
| - |
| - |
| - |
| ANGES |
| 05.04.26 |
|